Abstract

Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions

Author(s): Dho Lucile, Taleb Said Ait, Kireche Lyna, Rathelot Pascal, Primas Nicolas, Jean Christophe, Vanelle Patrice, Venet Arnaud, Curti Christophe

Issue: Mar/Apr 2026 - Volume 30, Number 2

Page(s): 184-196

Download in electronic PDF format for $75
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 1
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 2
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 3
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 4
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 5
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 6
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 7
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 8
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 9
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 10
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 11
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 12
  • Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions Page 13

Note: Electronic version includes supplemental material.

Abstract

Dipyridamole and clopidogrel are two antiplatelet agents that can be prescribed off-label in pediatric practice. As commercially available drugs are unavailable, pediatric formulations must be compounded. Both stability-indicating HPLC dosing assays and microbiological methods were validated and described. Stabilities of dipyridamole and clopidogrel in Syrspend® pH4 were studied. The stability study of clopidogrel involved two complementary HPLC methods (RP-HPLC and chiral HPLC). Oral suspension of 10 mg.mL-1 dipyridamole is stable for 3 months at +2/+8°C before opening, 1.5 month at +2/+8°C after opening, and 15 days at 25°C/60% RH. Oral suspension of 5 mg.mL-1 clopidogrel bisulfate is stable only for 1 month at +2/+8°C before or after opening and for 7 days at 25°C/60% RH.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2026
Pg. 184-196
May/Jun 2004
Pg. 181-185
Sep/Oct 2011
Pg. 435-437
Jul/Aug 2004
Pg. 269-274
Mar/Apr 2011
Pg. 158
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 129-134
Author(s): Rhoads Rick
May/Jun 2020
Pg. 252-262
Sep/Oct 2010
Pg. 430-435
Jan/Feb 2014
Pg. 6-12
Jul/Aug 2017
Pg. 339-346
Jan/Feb 2001
Pg. 9-12
Author(s): Schotik Debora
Jan/Feb 2001
Pg. 6-8
Author(s): Preckshot John
Nov/Dec 2012
Pg. 504
Author(s): Allen Loyd V Jr
Mar/Apr 2014
Pg. 162-168
May/Jun 2004
Pg. 206-209
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 453-463
Author(s): Timko Robert J
Sep/Oct 2009
Pg. 412-418
Author(s): Zolner William J
Jul/Aug 2006
Pg. 281-284
Author(s): Zolner William J
Jul/Aug 2005
Pg. 300-302
Sep/Oct 2003
Pg. 389-393